Tuesday, 05 July 2022

Jubilant opens new Chemistry Innovation Research Centre in Greater Noida

12 November 2021 | News

To support expanded discovery chemistry and in-vitro ADME services

Image Credit: Shutterstock

Image Credit: Shutterstock

Bengaluru-based contract research organisation (CRO) Jubilant Biosys has announced the expansion of its facilities to support its discovery chemistry and in-vitro ADME (absorption, distribution, metabolism, and excretion) Service offerings.


Jubilant Biosys provides services for Turning Point Therapeutics for multiple small molecule oncology research programmes. Turning Point is a precision oncology company developing next-generation therapies that target genetic drivers of cancer.


Services for Turning Point Therapeutics will be conducted out of the newly built state-of-the-art Chemistry Innovation Research Center (CIRC) in Greater Noida.


The CIRC has an initial capacity of 500 full-time equivalents (FTEs) enabling higher operational performance for discovery chemistry services and also rapid turn-around of in-vitro ADME data for client projects.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account